Detalhe da pesquisa
1.
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML.
Blood
; 132(11): 1125-1133, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045838
2.
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia.
Blood
; 131(4): 387-396, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29196412
3.
Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.
Haematologica
; 101(11): 1343-1350, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27418648
4.
Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia.
Pediatr Blood Cancer
; 62(6): 1048-54, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25662999
5.
A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia.
Br J Haematol
; 185(3): 623-627, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30203832
6.
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
Blood
; 119(16): 3705-11, 2012 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22378848
7.
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.
Blood
; 120(8): 1581-8, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22649108
8.
The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group.
Pediatr Blood Cancer
; 61(1): 81-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23956224
9.
High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group.
Br J Haematol
; 162(5): 670-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23826732
10.
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.
Blood
; 118(17): 4561-6, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21873548
11.
C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
Blood
; 116(25): 5638-49, 2010 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20889924
12.
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood
; 116(5): 702-10, 2010 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20413658
13.
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.
Blood
; 115(12): 2372-9, 2010 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20056794
14.
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood
; 113(26): 6558-66, 2009 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19304957
15.
Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 57(2): 204-9, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21504050
16.
FAM111B Mutation Is Associated With Inherited Exocrine Pancreatic Dysfunction.
Pancreas
; 45(6): 858-62, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26495788
17.
WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
J Clin Oncol
; 29(6): 704-11, 2011 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21189390
18.
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.
J Clin Oncol
; 28(17): 2831-8, 2010 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20421533